Bmp modulators in kidney disease
- PMID: 22284784
Bmp modulators in kidney disease
Abstract
Bone morphogenetic proteins (Bmps) are phylogenetically conserved signaling molecules that belong to the transforming growth factor beta superfamily. Although these proteins were first identified because of their ability to induce ectopic bone and cartilage formation, they are also involved in the cascades of body patterning and morphogenesis. Recently, several reports have indicated that the administration of pharmacological doses of Bmps inhibits and repairs acute and chronic renal injury in animal models. However, its mechanism of action and physiological function are not well understood. In addition, the exogenous administration of Bmps causes undesired side effects in other tissues, because Bmp receptors are widely expressed. The activities of Bmps are regulated by Bmp antagonists, which bind directly to Bmp and inhibit its binding to the receptor. Thus, the Bmp antagonists that modulate endogenous Bmp activities may be possible new therapeutic targets for kidney disease. In this review, we discuss recent findings related to Bmp antagonists modifying the function of Bmps in kidney disease.
Similar articles
-
Antagonists of bone morphogenetic proteins in kidney disease.Curr Opin Investig Drugs. 2010 Mar;11(3):315-22. Curr Opin Investig Drugs. 2010. PMID: 20178045 Review.
-
BMP antagonists: their roles in development and involvement in pathophysiology.Cytokine Growth Factor Rev. 2005 Jun;16(3):309-17. doi: 10.1016/j.cytogfr.2005.02.007. Cytokine Growth Factor Rev. 2005. PMID: 15951218 Review.
-
BMP modulators regulate the function of BMP during body patterning and disease progression.Biofactors. 2009 Mar-Apr;35(2):113-9. doi: 10.1002/biof.15. Biofactors. 2009. PMID: 19449438 Review.
-
[BMP in the kidney: signaling, function and pathophysiological significance].Clin Calcium. 2007 May;17(5):704-10. Clin Calcium. 2007. PMID: 17470999 Review. Japanese.
-
Bone morphogenetic proteins and their antagonists.Rev Endocr Metab Disord. 2006 Jun;7(1-2):51-65. doi: 10.1007/s11154-006-9000-6. Rev Endocr Metab Disord. 2006. PMID: 17029022 Review.
Cited by
-
Uterine Sensitization-Associated Gene-1 in the Progression of Kidney Diseases.J Immunol Res. 2021 Aug 7;2021:9752139. doi: 10.1155/2021/9752139. eCollection 2021. J Immunol Res. 2021. PMID: 34414243 Free PMC article. Review.
-
Use of bone morphogenetic proteins in mesenchymal stem cell stimulation of cartilage and bone repair.World J Stem Cells. 2016 Jan 26;8(1):1-12. doi: 10.4252/wjsc.v8.i1.1. World J Stem Cells. 2016. PMID: 26839636 Free PMC article. Review.
-
Formation and characterization of BMP2/GDF5 and BMP4/GDF5 heterodimers.BMC Biol. 2023 Feb 1;21(1):16. doi: 10.1186/s12915-023-01522-4. BMC Biol. 2023. PMID: 36726183 Free PMC article.
-
Bone morphogenetic proteins and inner ear development.J Zhejiang Univ Sci B. 2019 Feb.;20(2):131-145. doi: 10.1631/jzus.B1800084. Epub 2018 Aug 4. J Zhejiang Univ Sci B. 2019. PMID: 30112880 Free PMC article. Review.
-
The Growth Factors: Potential Biomarkers and Therapeutic Targets in Kidney Diseases.Kidney Dis (Basel). 2022 Sep 12;8(5):368-380. doi: 10.1159/000526208. eCollection 2022 Nov. Kidney Dis (Basel). 2022. PMID: 36466071 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
